NASDAQ
No price data available for this timeframe.
Celldex Therapeutics, Inc. (CLDX) has a free cash flow growth of -3.53% as of Friday, May 29, 2026. This represents a 84.00% increase compared to its 12-month average of -22.08%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.